학술논문
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/ refractory B-cell non-Hodgkin lymphoma
Document Type
Article
Author
Source
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 21 March 2024, 12(3))
Subject
Language
English
ISSN
20511426